A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract Infections

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(22 sites)

Czechia

Fakultni nemocnice Ostrava, Ostrava

Faculty Hospital Kralovske Vinohrady, Paediatric Clinic, Prague

France

Hôpital mère-enfant - CHU de Nantes, Nantes

Nice University Hospital (CHU de Nice), Nice

Hospital Armand Trousseau Clinical Research Site, Paris